Information Provided By:
Fly News Breaks for December 6, 2019
Dec 6, 2019 | 08:49 EDT
Baird analyst Madhu Kumar said his optimism on Rocket Pharmaceuticals leads him to raise his price target to $41 from $30 ahead of the release of its ASH data on December 08. He also raised his launch probability to 30% and elevated the shares to Fresh Pick. Kumar reiterated his Outperform rating on Rocket Pharmaceuticals shares.
News For RCKT From the Last 2 Days
There are no results for your query RCKT